Group vs Individual Interventions for HIV Prevention
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that the SISTA intervention, which is part of the treatment, led to a significant reduction in sexual risk behaviors among African American women, such as having less unprotected sex, when implemented in community settings.
12345The available research on the SISTA intervention, which is designed for HIV prevention among African American women, does not report any safety concerns or adverse effects, suggesting it is generally safe for human participants.
13567The DADA treatment, also known as SISTA, is unique because it is a culturally relevant, gender-specific group intervention designed specifically for African American women, focusing on reducing sexual risk through education and empowerment in a supportive group setting.
238910Eligibility Criteria
This trial is for HIV-negative, African-born Black or mixed-Black cis-gender women aged 18-45 living in Greater Boston Area or New York City. Participants must speak English or French and have had unprotected sex recently. Pregnant women, men, and transgender individuals cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment and Randomization
Participants complete baseline assessments and are randomized to either the individual-level or group-level intervention
Intervention Delivery
Participants receive either the Dada Kwa Dada (individual-level) or DADA (group-level) intervention virtually
Follow-up
Participants are monitored for primary outcomes such as PrEP uptake and condom use at 3 and 6 months